Updates on morphea: Role of vascular injury and advances in treatment

Autoimmune Diseases

Volumn 2013, Issue , 2013, Pages

  Sartori Valinotti, Julio C ^a   Tollefson, Megha M ^a   Reed, Ann M ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; FIBRILLIN 1; IMATINIB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PROSTACYCLIN; RITUXIMAB; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; B LYMPHOCYTE ACTIVATION; BLOOD VESSEL INJURY; CLINICAL FEATURE; COLLAGEN SYNTHESIS; DRUG EFFICACY; ECHOGRAPHY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GRAFT VERSUS HOST REACTION; HEMIFACIAL ATROPHY; HUMAN; ISCHEMIA; LINEAR SCLERODERMA; LOCALIZED SCLERODERMA; MORPHEA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUVA; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SKIN PIGMENTATION; SYNDROME CREST; SYSTEMIC SCLEROSIS; T LYMPHOCYTE ACTIVATION; TISSUE BLOOD FLOW; ULTRAVIOLET A RADIATION;

EID: 84890064427     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2013/467808     Document Type: Review

References (73)

1. Laxer R. M., Zulian F., Localized scleroderma. Current Opinion in Rheumatology 2006 18 6 606 613 2-s2.0-33750215288 10.1097/01.bor.0000245727. 40630.c3 (Pubitemid 44607414)
2. Peterson L. S., Nelson A. M., Su W. P. D., Classification of morphea (localized scleroderma). Mayo Clinic Proceedings 1995 70 11 1068 1076 2-s2.0-0028788272
3. Chiu Y. E., Vora S., Kwon E. K., Maheshwari M., A significant proportion of children with morphea en coup de sabre and Parry-Romberg syndrome have neuroimaging findings. Pediatric Dermatology 2012 29 738 748
4. Frech T. M., Revelo M. P., Drakos S. G., Vascular leak is a central feature in the pathogenesis of systemic sclerosis. The Journal of Rheumatology 2012 39 1385 1391
5. Hasegawa M., Sato S., Nagaoka T., Fujimoto M., Takehara K., Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma. Dermatology 2003 207 2 141 147 2-s2.0-0042386702 10.1159/000071783 (Pubitemid 37034341)
6. Higley H., Persichitte K., Chu S., Waegell W., Vancheeswaran R., Black C., Immunocytochemical localization and serologic detection of transforming growth factor β 1: association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis and Rheumatism 1994 37 2 278 288 2-s2.0-0028009496
7. Ihn H., Sato S., Fujimoto M., Kikuchi K., Takehara K., Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma. Archives of Dermatological Research 1995 287 2 193 197 2-s2.0-0028937326 10.1007/BF01262331
8. Kahari V.-M., Sandberg M., Kalimo H., Vuorio T., Vuorio E., Identification of fibroblasts responsible for increased collagen production in localized scleroderma by in situ hybridization. Journal of Investigative Dermatology 1988 90 5 664 670 2-s2.0-0023876160
9. Sgonc R., Gruschwitz M. S., Dietrich H., Recheis H., Gershwin M. E., Wick G., Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. The Journal of Clinical Investigation 1996 98 3 785 792 2-s2.0-0029999963 (Pubitemid 26349184)
10. Cipriani P., Marrelli A., Liakouli V., Di Benedetto P., Giacomelli R., Cellular players in angiogenesis during the course of systemic sclerosis. Autoimmunity Reviews 2011 10 10 641 646 2-s2.0-80051667736 10.1016/j.autrev. 2011.04.016
11. Hamamdzic D., Harley R. A., Hazen-Martin D., LeRoy E. C., MCMV induces neointima in IFN- γ R-/- mice: intimal cell apoptosis and persistent proliferation of myofibroblasts. BMC Musculoskeletal Disorders 2001 2, article 1 2-s2.0-3142581897 10.1186/1471-2474-2-1
12. Magro C. M., Crowson A. N., Ferri C., Cytomegalovirus-associated cutaneous vasculopathy and scleroderma sans inclusion body change. Human Pathology 2007 38 1 42 49 2-s2.0-33845318243 10.1016/j.humpath.2006.06.002 (Pubitemid 44880199)
13. Magro C. M., Nuovo G., Ferri C., Crowson A. N., Giuggioli D., Sebastiani M., Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma. Journal of Cutaneous Pathology 2004 31 1 43 50 2-s2.0-1642521898 10.1046/j.0303-6987.2003.0143.x (Pubitemid 38130275)
14. Koca S. S., Isik A., Ozercan I. H., Ustundag B., Evren B., Metin K., Effectiveness of etanercept in bleomycin-induced experimental scleroderma. Rheumatology 2008 47 2 172 175 2-s2.0-38649087353 10.1093/rheumatology/kem344 (Pubitemid 351168226)
15. Lunardi C., Dolcino M., Peterlana D., Bason C., Navone R., Tamassia N., Beri R., Corrocher R., Puccetti A., Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: a gene array approach. PLoS Medicine 2006 3 1, article e2 2-s2.0-32044456248 10.1371/journal.pmed.0030002 (Pubitemid 43200636)
16. Pastano R., Dell'Agnola C., Bason C., Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease. International Immunology 2012 24 583 591
17. Ratanatharathorn V., Ayash L., Reynolds C., Silver S., Reddy P., Becker M., Ferrara J. L. M., Uberti J. P., Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biology of Blood and Marrow Transplantation 2003 9 8 505 511 2-s2.0-1542472753 10.1016/S1083-8791(03)00216- 7 (Pubitemid 38351794)
18. Barnes T. C., Spiller D. G., Anderson M. E., Edwards S. W., Moots R. J., Endothelial activation and apoptosis mediated by neutrophil-dependent interleukin 6 trans-signalling: a novel target for systemic sclerosis? Annals of the Rheumatic Diseases 2011 70 2 366 372 2-s2.0-78751704435 10.1136/ard.2010.133587
19. Sgonc R., Gruschwitz M. S., Boeck G., Sepp N., Gruber J., Wick G., Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis and Rheumatism 2000 43 2550 2562
20. Distler J. H. W., Akhmetshina A., Dees C., Jüngel A., Stürzl M., Gay S., Pisetsky D. S., Schett G., Distler O., Induction of apoptosis in circulating angiogenic cells by microparticles. Arthritis and Rheumatism 2011 63 7 2067 2077 2-s2.0-79959835842 10.1002/art.30361
21. Guiducci S., Distler J. H. W., Jüngel A., Huscher D., Huber L. C., Michel B. A., Gay R. E., Pisetsky D. S., Gay S., Matucci-Cerinic M., Distler O., The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis and Rheumatism 2008 58 9 2845 2853 2-s2.0-51849160858 10.1002/art.23735
22. Distler J. H. W., Huber L. C., Gay S., Distler O., Pisetsky D. S., Microparticles as mediators of cellular cross-talk in inflammatory disease. Autoimmunity 2006 39 8 683 690 2-s2.0-33845702611 10.1080/08916930601061538 (Pubitemid 44964371)
23. Chabaud S., Corriveau M.-P., Grodzicky T., Senécal J.-L., Chartier S., Raymond Y., Moulin V. J., Decreased secretion of MMP by non-lesional late-stage scleroderma fibroblasts after selection via activation of the apoptotic fas-pathway. Journal of Cellular Physiology 2011 226 7 1907 1914 2-s2.0-79955002341 10.1002/jcp.22520
24. Samuel G. H., Lenna S., Bujor A. M., Lafyatis R., Trojanowska M., Acid sphingomyelinase deficiency contributes to resistance of scleroderma fibroblasts to Fas-mediated apoptosis. Journal of Dermatological Science 2012 67 166 172
25. Mihai C., Tervaert J. W. C., Anti-endothelial cell antibodies in systemic sclerosis. Annals of the Rheumatic Diseases 2010 69 2 319 324 2-s2.0-75749103768 10.1136/ard.2008.102400
26. Abraham D., Distler O., How does endothelial cell injury start? The role of endothelin in systemic sclerosis. Arthritis Research and Therapy 2007 9 supplement 2, article S2 2-s2.0-35349019900 10.1186/ar2186
27. Dib H., Tamby M. C., Bussone G., Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma. European Respiratory Journal 2012 39 1405 1414
28. Lewandowska K., Ciurzynski M., Gorska E., Antiendothelial cells antibodies in patients with systemic sclerosis in relation to pulmonary hypertension and lung fibrosis. Advances in Experimental Medicine and Biology 2013 756 147 153
29. Avouac J., Cagnard N., Distler J. H., Schoindre Y., Ruiz B., Couraud P. O., Uzan G., Boileau C., Chiocchia G., Allanore Y., Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells. Arthritis and Rheumatism 2011 63 11 3552 3562 2-s2.0-80155127962 10.1002/art.30536
30. Selmi C., Feghali-Bostwick C. A., Lleo A., X chromosome gene methylation in peripheral lymphocytes from monozygotic twins discordant for scleroderma. Clinical & Experimental Immunology 2012 169 253 262
31. Bielecki M., Kowal K., Lapinska A., Chwiesko-Minarowska S., Chyczewski L., Kowal-Bielecka O., Peripheral blood mononuclear cells from patients with systemic sclerosis spontaneously secrete increased amounts of vascular endothelial growth factor (VEGF) already in the early stage of the disease. Advances in Medical Sciences 2011 56 2 255 263 2-s2.0-84855452428 10.2478/v10039-011-0025-z
32. Carrai V., Miniati I., Guiducci S., Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis. Rheumatology 2012 51 1042 1048
33. Del Papa N., Quirici N., Scavullo C., Gianelli U., Corti L., Vitali C., Ferri C., Giuggioli D., Manfredi A., Maglione W., Onida F., Colaci M., Bosari S., Deliliers G. L., Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. The Journal of Rheumatology 2010 37 10 2053 2063 2-s2.0-77957886342 10.3899/jrheum.091346
34. Bielecki M., Kowal K., Lapinska A., Chwiecko J., Skowronski J., Sierakowski S., Chyczewski L., Kowal-Bielecka O., Diminished production of TWEAK by the peripheral blood mononuclear cells is associated with vascular involvement in patients with systemic sclerosis. Folia Histochemica et Cytobiologica 2009 47 3 465 469 2-s2.0-77149160386 10.2478/v10042-009-0103-2
35. Wortsman X., Wortsman J., Sazunic I., Carreño L., Activity assessment in morphea using color Doppler ultrasound. Journal of the American Academy of Dermatology 2011 65 5 942 948 2-s2.0-80054118059 10.1016/j.jaad.2010. 08.027
36. Nezafati K. A., Cayce R. L., Susa J. S., Setiawan A. T., Tirkes T., Bendeck S. E., Jacobe H. T., 14-MHz ultrasonography as an outcome measure in morphea (localized scleroderma). Archives of Dermatology 2011 147 9 1112 1115 2-s2.0-80053077634 10.1001/archdermatol.2011.243
37. Li S. C., Liebling M. S., Haines K. A., Weiss J. E., Prann A., Initial evaluation of an ultrasound measure for assessing the activity of skin lesions in juvenile localized scleroderma. Arthritis Care and Research 2011 63 5 735 742 2-s2.0-79958858516 10.1002/acr.20407
38. Szymańska E., Maj M., Majsterek M., Litniewski J., Nowicki A., Rudnicka L., The usefulness of high frequency ultrasonography in dermatologlcal practice-ultrasound features of selected cutaneous lesions. Polski Merkuriusz Lekarski 2011 31 181 37 40 2-s2.0-80052102643
39. Iagnocco A., Ceccarelli F., Vavala C., Ultrasound in the assessment of musculoskeletal involvement in systemic sclerosis. Medical Ultrasonography 2012 14 231 234
40. Fernandes T. M., Bica B. E., Villela N. R., Evaluation of endothelial function in patients with limited systemic sclerosis by use of brachial artery Doppler ultrasound. Revista Brasileira de Reumatologia 2012 52 561 568
41. Osmola-Mankowska A., Silny W., Danczak-Pazdrowska A., Assessment of chronic sclerodermoid Graft-versus-Host Disease patients, using 20 MHz high-frequency ultrasonography and cutometer methods. Skin Research and Technology 2013 19 1 e417 e422 10.1111/j.1600-0846.2012.00659.x
42. Li S. C., Liebling M. S., Haines K. A., Ultrasonography is a sensitive tool for monitoring localized scleroderma. Rheumatology 2007 46 8 1316 1319 2-s2.0-34547840144 10.1093/rheumatology/kem120 (Pubitemid 47244508)
43. Buense R., Duarte I. A., Bouer M., Localized scleroderma: assessment of the therapeutic response to phototherapy. Anais Brasileiros de Dermatologia 2012 87 63 69
44. Pope E., Doria A. S., Theriault M., Mohanta A., Laxer R. M., Topical imiquimod 5% cream for pediatric plaque morphea: a prospective, multiple-baseline, open-label pilot study. Dermatology 2011 223 4 363 369 2-s2.0-84858437643 10.1159/000335560
45. Schanz S., Fierlbeck G., Ulmer A., Schmalzing M., Kümmerle-Deschner J., Claussen C. D., Horger M., Localized scleroderma: MR findings and clinical features. Radiology 2011 260 3 817 824 2-s2.0-84860415027 10.1148/radiol. 11102136
46. Schanz S., Henes J., Ulmer A., Magnetic resonance imaging findings in patients with systemic scleroderma and musculoskeletal symptoms. European Radiology 2013 23 212 221
47. Schanz S., Henes J., Ulmer A., Response evaluation of musculoskeletal involvement in patients with deep morphea treated with methotrexate and prednisolone: a combined MRI and clinical approach. American Journal of Roentgenology 2013 200 376 382
48. Zulian F., Vallongo C., Patrizi A., A long-term follow-up study of methotrexate in juvenile localized scleroderma (morphea). Journal of the American Academy of Dermatology 2012 67 1151 1156
49. Torok K. S., Arkachaisri T., Methotrexate and corticosteroids in the treatment of localized scleroderma: a standardized prospective longitudinal single-center study. The Journal of Rheumatology 2012 39 2 286 294 2-s2.0-84856557868 10.3899/jrheum.110210
50. Inamo Y., Ochiai T., Successful combination treatment of a patient with progressive Juvenile Localized Scleroderma (Morphea) using Imatinib, Corticosteroids, and Methotrexate. Pediatric Dermatology 2012 10.1111/j.1525-1470.2012.01882.x
51. Reitamo S., Remitz A., Varga J., Ceska M., Effenberger F., Jimenez S., Uitto J., Demonstration of interleukin 8 and autoantibodies to interleukin 8 in the serum of patients with systemic sclerosis and related disorders. Archives of Dermatology 1993 129 2 189 193 2-s2.0-0027397988 10.1001/archderm.129.2.189 (Pubitemid 23063871)
52. Visvanathan S., Marini J. C., Smolen J. S., St. Clair E. W., Pritchard C., Shergy W., Pendley C., Baker D., Bala M., Gathany T., Han J., Wagner C., Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis. The Journal of Rheumatology 2007 34 7 1465 1474 2-s2.0-34447515614 (Pubitemid 47067980)
53. Pope J. E., Bellamy N., Seibold J. R., A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis and Rheumatism 2001 44 1351 1358 (Pubitemid 32537533)
54. van den Hoogen F. H. J., Boerbooms A. M. T., Swaak A. J. G., Rasker J. J., van Lier H. J. J., van de Putte L. B. A., Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial. British Journal of Rheumatology 1996 35 4 364 372 2-s2.0-0029867337
55. Derk C. T., Grace E., Shenin M., Naik M., Schulz S., Xiong W., A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis. Rheumatology 2009 48 12 1595 1599 2-s2.0-75649109604 10.1093/rheumatology/kep295
56. Fett N., Werth V. P., Update on morphea: part II. Outcome measures and treatment. Journal of the American Academy of Dermatology 2011 64 2 231 242 2-s2.0-78751507136 10.1016/j.jaad.2010.05.046
57. George L., George B., Gottlieb D. J., Hertzberg M., Fernandez-Peñas P., Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD. Bone Marrow Transplantation 2012 47 737 738 2-s2.0-79960559938 10.1038/bmt.2011.150
58. Chimenti M. S., Teoli M., Stefani A. D., Giunta A., Esposito M., Perricone R., Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis. European Journal of Dermatology 2013 23 2 273 274
59. Kerscher M., Vokenandt M., Meurer M., Lehmann P., Plewig G., Rocken M., Treatment of localised scleroderma with PUVA bath photochemotherapy. The Lancet 1994 343 8907 1233 2-s2.0-0028226549 (Pubitemid 24147585)
60. El-Mofty M., Mostafa W., Esmat S., Youssef R., Bousseila M., Nagi N., Shaker O., Abouzeid A., Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study. Photodermatology Photoimmunology and Photomedicine 2004 20 2 93 100 2-s2.0-1842536514 10.1111/j.1600-0781.2004.00080.x (Pubitemid 38455739)
61. Morita A., Kobayashi K., Isomura I., Tsuji T., Krutmann J., Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis. Journal of the American Academy of Dermatology 2000 43 4 670 674 2-s2.0-0033781383
62. Scharffetter K., Wlaschek M., Hogg A., Bolsen K., Schothorst A., Goerz G., Krieg T., Plewig G., UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo. Archives of Dermatological Research 1991 283 8 506 511 2-s2.0-0026315768
63. Stein B., Rahmsdorf H. J., Steffen A., Litfin M., Herrlich P., UV-induced DNA damage is an intermediate step in UV-induced expression of human immunodeficiency virus type 1, collagenase, c-fos, and metallothionein. Molecular and Cellular Biology 1989 9 11 5169 5181 2-s2.0-0024404496 (Pubitemid 19275988)
64. El-Mofty M., Mostafa W., El-Darouty M., Bosseila M., Nada H., Yousef R., Esmat S., El-Lawindy M., Assaf M., El-Enani G., Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis. A clinico-pathologic study. Photodermatology Photoimmunology and Photomedicine 2004 20 3 148 156 2-s2.0-2942571905 10.1111/j.1600-0781.2004.00081.x (Pubitemid 38744933)
65. El-Mofty M., Zaher H., Bosseila M., Yousef R., Saad B., Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatology Photoimmunology and Photomedicine 2000 16 2 43 49 2-s2.0-0034017066 (Pubitemid 30230383)
66. Kreuter A., Hyun J., Stücker M., Sommer A., Altmeyer P., Gambichler T., A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. Journal of the American Academy of Dermatology 2006 54 3 440 447 2-s2.0-32644449006 10.1016/j.jaad.2005.11.1063 (Pubitemid 43243447)
67. Zwischenberger B. A., Jacobe H. T., A systematic review of morphea treatments and therapeutic algorithm. Journal of the American Academy of Dermatology 2011 65 5 925 941 2-s2.0-80054115914 10.1016/j.jaad.2010.09.006
68. Kreuter A., Breuckmann F., Uhle A., Brockmeyer N., Von Kobyletzki G., Freitag M., Stuecker M., Hoffmann K., Gambichler T., Altmeyer P., Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. Journal of the American Academy of Dermatology 2004 50 5 740 747 2-s2.0-2342649549 10.1016/j.jaad.2003.08.026 (Pubitemid 38580553)
69. Tuchinda C., Kerr H. A., Taylor C. R., Jacobe H., Bergamo B. M., Elmets C., Rivard J., Lim H. W., UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States. Photodermatology Photoimmunology and Photomedicine 2006 22 5 247 253 2-s2.0-33748285230 10.1111/j.1600-0781.2006. 00245.x (Pubitemid 44317158)
70. Pereira N., Santiago F., Oliveira H., Figueiredo A., Low-dose UVA1 phototherapy for scleroderma: what benefit can we expect? Journal of the European Academy of Dermatology and Venereology 2012 26 5 619 626 2-s2.0-84857576743 10.1111/j.1468-3083.2011.04137.x
71. Xu H., Zaidi M., Struve J., Jones D. W., Krolikowski J. G., Nandedkar S., Lohr N. L., Gadicherla A., Pagel P. S., Csuka M. E., Pritchard K. A., Weihrauch D., Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis. American Journal of Physiology-Cell Physiology 2011 300 3 C550 C556 2-s2.0-79952158516 10.1152/ajpcell.00123.2010
72. Tinazzi E., Dolcino M., Puccetti A., Rigo A., Beri R., Valenti M. T., Corrocher R., Lunardi C., Gene expression profiling in circulating endothelial cells from systemic sclerosis patients shows an altered control of apoptosis and angiogenesis that is modified by iloprost infusion. Arthritis Research and Therapy 2010 12 4, article R131 2-s2.0-77954282503 10.1186/ar3069
73. Ferri C., Giuggioli D., Manfredi A., Quirici N., Scavullo C., Colaci M., Gianelli U., Lambertenghi Deliliers G., Del Papa N., Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. Clinical and Experimental Dermatology 2010 35 8 885 887 2-s2.0-78149362868 10.1111/j.1365-2230.2010.03847. x